1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.10. | LumiraDx Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 01.08. | BioPharma Credit PLC - STATEMENT RE LUMIRADX | 5 | RNS | ||
| 29.07. | Roche Closes Acquisition Of LumiraDx's Point Of Care Technology | 439 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG (RHHBY), a Swiss healthcare major, on Monday said that it has concluded the previously announced acquisition of LumiraDx Limited's (LMDX) Point... ► Artikel lesen | |
| 29.07. | BioPharma Credit PLC - STATEMENT RE LUMIRADX | 5 | RNS | ||
| LUMIRADX Aktie jetzt für 0€ handeln | |||||
| 29.07. | F. Hoffmann-La Roche Ltd: Roche closes acquisition of LumiraDx's Point of Care technology to expand access to diagnostic testing in primary care | 601 | GlobeNewswire (Europe) | The acquisition of LumiraDx's Point of Care technology received all required antitrust and regulatory clearances.LumiraDx's transformative Point of Care solution will complement Roche's diagnostics... ► Artikel lesen | |
| 24.05. | Competition Watchdog CMA Issues Prelim. Notice To Roche On Its Merger Plan With LumiraDx | 557 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - The Competition and Markets Authority or CMA on Friday said that it has issued a notice regarding Roche's planned acquisition of certain assets of LumiraDx, under... ► Artikel lesen | |
| 24.05. | Britische Wettbewerbsaufsicht CMA prüft Roche-LumiraDx-Deal | 549 | Dow Jones News | DJ Britische Wettbewerbsaufsicht CMA prüft Roche-LumiraDx-Deal
Von Michael Susin
LONDON (Dow Jones)--Die britische Wettbewerbs- und Marktaufsichtsbehörde CMA hat eine Prüfung der Übernahme... ► Artikel lesen | |
| 20.05. | CMA Invites Views From Interested Parties On Roche, LumiraDx Deal | 543 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - The UK's Competition and Markets Authority or CMA said on Monday that it decided to investigate the planned acquisition by Roche Diagnostics Limited ((RHHBY))... ► Artikel lesen | |
| 20.05. | CMA wägt mögliche Auswirkungen von Roche-LumiraDx-Deal ab | 589 | Dow Jones News | DJ CMA wägt mögliche Auswirkungen von Roche-LumiraDx-Deal ab
Von Mauro Orru
LONDON (Dow Jones)--Die britische Wettbewerbs- und Marktaufsichtsbehörde CMA prüft, ob die Übernahme sogenannter... ► Artikel lesen | |
| 20.03. | Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival ... | 361 | GlobeNewswire (Europe) | NEW YORK" March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.'s securities were suspended on August... ► Artikel lesen | |
| 05.01. | LumiraDx Limited: LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th | 439 | GlobeNewswire (Europe) | LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities... ► Artikel lesen | |
| 29.12.23 | F. Hoffmann-La Roche Ltd: Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform | 1.014 | GlobeNewswire (Europe) | The transformative point of care solution will complement Roche's centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coagulation and Molecular, and across multiple disease... ► Artikel lesen | |
| 29.12.23 | LumiraDx Limited: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche | 879 | GlobeNewswire (Europe) | LONDON, Dec. 29, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX) (the "Company"), a next generation point of care diagnostics company, announced today the appointment of joint administrators... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,254 | +0,63 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,865 | -1,03 % | Tempest Therapeutics: Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update | Building upon a successful end-of-Phase 2 meeting, received FDA "Study May Proceed" letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced agreement... ► Artikel lesen | |
| NANO-X IMAGING | 6,350 | +3,08 % | Nano-X Imaging Ltd reports results for the quarter ended September 30 - Earnings Summary | ||
| BUTTERFLY NETWORK | 3,230 | -1,67 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| INTELLIGENT BIO SOLUTIONS | 1,475 | -100,00 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| GOODRX | 4,905 | +14,34 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,450 | +4,23 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,060 | +0,19 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,830 | +2,25 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| MIMEDX | 9,190 | -0,22 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 1,020 | +3,66 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 93,60 | -0,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 15,440 | +3,17 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| BIOMERICA | 0,320 | -1,05 % | Biomerica secures patents for GI treatments in Europe | ||
| ATRICURE | 35,730 | +0,08 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen |
LUMIRADX LIMITED gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,016 Euro und damit -1,25 % im Minus.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LUMIRADX LIMITED finden Sie auf Wallstreet Online.
